| ■ 영문 제목 : Global Biologics CDMO Market 2023-2027
|
 | ■ 상품코드 : IRTNTR72001-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 2월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 기타 지역
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,375,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사(테크나비오)는 세계의 생물 제제 CDMO 시장 규모가 2022년부터 2027년 사이에 132.6억 달러에 달하며, 예측 기간 동안 연평균 13.97% 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 생물 제제 CDMO 시장에 대해 조사 및 분석하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, 파이브 포스 분석, 종류별 (포유류, 미생물) 분석, 제품 종류별 (생물 제제, 바이오 시밀러) 분석, 고객 현황, 지역별 현황 (북미, 아시아 태평양, 유럽, 중동 및 아프리카, 남미, 미국, 중국, 독일, 영국, 일본) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 수록하고 있습니다. 또한 본 조사 보고서는 3P BIOPHARMACEUTICALS S.L.U., AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals Co. Ltd., Catalent Inc., Cytovance Biologics, Evonik Industries AG, FUJIFIL 등의 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・파이브 포스 분석
・세계의 생물 제제 CDMO 시장 규모 : 제품별
- 포유류 CDMO의 시장 규모
- 미생물 CDMO의 시장 규모
・세계의 생물 제제 CDMO 시장 규모 : 제품 종류별
- 생물 제제의 시장 규모
- 바이오 시밀러의 시장 규모
・고객 현황
・지역별 현황
- 북미의 생물 제제 CDMO 시장 규모
- 유럽의 생물 제제 CDMO 시장 규모
- 아시아 태평양의 생물 제제 CDMO 시장 규모
- 기타 지역의 생물 제제 CDMO 시장 규모
- 미국의 생물 제제 CDMO 시장 규모
- 캐나다의 생물 제제 CDMO 시장 규모
- 독일의 생물 제제 CDMO 시장 규모
- 영국의 생물 제제 CDMO 시장 규모
- 일본의 생물 제제 CDMO 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 생물 제제 CDMO 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 생물 제제 CDMO 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Biologics CDMO Market 2023-2027Technavio has been monitoring the biologics CDMO market and is forecast to grow by $13.26 bn during 2022-2027, accelerating at a CAGR of 13.97% during the forecast period. Our report on the biologics CDMO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of cost-efficient resources in emerging markets, strong research and development pipeline of biologics therapeutics, and a growing need to focus on core competencies.
Technavio’s biologics CDMO market is segmented as below:
By Type
• Mammalian
• Microbial
By Product Type
• Biologics
• Biosimilars
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the advent of big data as one of the prime reasons driving the biologics CDMO market growth during the next few years. Also, strategic alliances and partnerships with pharma companies and increasing approvals for new molecules and biosimilars will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the biologics CDMO market covers the following areas:
• Biologics CDMO market sizing
• Biologics CDMO market forecast
• Biologics CDMO market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologics CDMO market vendors that include 3P BIOPHARMACEUTICALS S.L.U., AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals Co. Ltd., Catalent Inc., Cytovance Biologics, Evonik Industries AG, FUJIFILM Holdings Corp, Grifols SA, JRS PHARMA GmbH and Co. KG, JSR Corp., Kemwell Biopharma Pvt. Ltd., KLOCKE GROUP, Lonza Group Ltd., Novartis AG, Rentschler Biopharma SE, Samsung Biologics Co. Ltd., Toyobo Co. Ltd., and WuXi Biologics Cayman Inc. Also, the biologics CDMO market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biologics CDMO market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global biologics CDMO market 2017 – 2021 ($ billion)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
o 4.3 Product type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product type Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Mammalian – Market size and forecast 2022-2027
o Exhibit 34: Chart on Mammalian – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Mammalian – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Mammalian – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Mammalian – Year-over-year growth 2022-2027 (%)
o 6.4 Microbial – Market size and forecast 2022-2027
o Exhibit 38: Chart on Microbial – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Microbial – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Microbial – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Microbial – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
• 7 Market Segmentation by Product Type
o 7.1 Market segments
o Exhibit 43: Chart on Product Type – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Product Type – Market share 2022-2027 (%)
o 7.2 Comparison by Product Type
o Exhibit 45: Chart on Comparison by Product Type
o Exhibit 46: Data Table on Comparison by Product Type
o 7.3 Biologics – Market size and forecast 2022-2027
o Exhibit 47: Chart on Biologics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on Biologics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on Biologics – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Biologics – Year-over-year growth 2022-2027 (%)
o 7.4 Biosimilars – Market size and forecast 2022-2027
o Exhibit 51: Chart on Biosimilars – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Biosimilars – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Biosimilars – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Biosimilars – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product Type
o Exhibit 55: Market opportunity by Product Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share by geography 2022-2027 (%)
o Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 81: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 89: Chart on France – Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on France – Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 97: Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 104: AbbVie Inc. – Overview
o Exhibit 105: AbbVie Inc. – Product / Service
o Exhibit 106: AbbVie Inc. – Key news
o Exhibit 107: AbbVie Inc. – Key offerings
o 12.4 Binex Co. Ltd.
o Exhibit 108: Binex Co. Ltd. – Overview
o Exhibit 109: Binex Co. Ltd. – Product / Service
o Exhibit 110: Binex Co. Ltd. – Key offerings
o 12.5 Boehringer Ingelheim International GmbH
o Exhibit 111: Boehringer Ingelheim International GmbH – Overview
o Exhibit 112: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 113: Boehringer Ingelheim International GmbH – Key news
o Exhibit 114: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 115: Boehringer Ingelheim International GmbH – Segment focus
o 12.6 Bora Pharmaceuticals Co. Ltd.
o Exhibit 116: Bora Pharmaceuticals Co. Ltd. – Overview
o Exhibit 117: Bora Pharmaceuticals Co. Ltd. – Product / Service
o Exhibit 118: Bora Pharmaceuticals Co. Ltd. – Key offerings
o 12.7 Catalent Inc.
o Exhibit 119: Catalent Inc. – Overview
o Exhibit 120: Catalent Inc. – Business segments
o Exhibit 121: Catalent Inc. – Key news
o Exhibit 122: Catalent Inc. – Key offerings
o Exhibit 123: Catalent Inc. – Segment focus
o 12.8 Evonik Industries AG
o Exhibit 124: Evonik Industries AG – Overview
o Exhibit 125: Evonik Industries AG – Business segments
o Exhibit 126: Evonik Industries AG – Key news
o Exhibit 127: Evonik Industries AG – Key offerings
o Exhibit 128: Evonik Industries AG – Segment focus
o 12.9 FUJIFILM Holdings Corp
o Exhibit 129: FUJIFILM Holdings Corp – Overview
o Exhibit 130: FUJIFILM Holdings Corp – Business segments
o Exhibit 131: FUJIFILM Holdings Corp – Key offerings
o Exhibit 132: FUJIFILM Holdings Corp – Segment focus
o 12.10 Grifols SA
o Exhibit 133: Grifols SA – Overview
o Exhibit 134: Grifols SA – Business segments
o Exhibit 135: Grifols SA – Key offerings
o Exhibit 136: Grifols SA – Segment focus
o 12.11 JRS PHARMA GmbH and Co. KG
o Exhibit 137: JRS PHARMA GmbH and Co. KG – Overview
o Exhibit 138: JRS PHARMA GmbH and Co. KG – Product / Service
o Exhibit 139: JRS PHARMA GmbH and Co. KG – Key offerings
o 12.12 Lonza Group Ltd.
o Exhibit 140: Lonza Group Ltd. – Overview
o Exhibit 141: Lonza Group Ltd. – Business segments
o Exhibit 142: Lonza Group Ltd. – Key news
o Exhibit 143: Lonza Group Ltd. – Key offerings
o Exhibit 144: Lonza Group Ltd. – Segment focus
o 12.13 Novartis AG
o Exhibit 145: Novartis AG – Overview
o Exhibit 146: Novartis AG – Business segments
o Exhibit 147: Novartis AG – Key offerings
o Exhibit 148: Novartis AG – Segment focus
o 12.14 Rentschler Biopharma SE
o Exhibit 149: Rentschler Biopharma SE – Overview
o Exhibit 150: Rentschler Biopharma SE – Product / Service
o Exhibit 151: Rentschler Biopharma SE – Key offerings
o 12.15 Samsung Biologics Co. Ltd.
o Exhibit 152: Samsung Biologics Co. Ltd. – Overview
o Exhibit 153: Samsung Biologics Co. Ltd. – Product / Service
o Exhibit 154: Samsung Biologics Co. Ltd. – Key offerings
o 12.16 Toyobo Co. Ltd.
o Exhibit 155: Toyobo Co. Ltd. – Overview
o Exhibit 156: Toyobo Co. Ltd. – Business segments
o Exhibit 157: Toyobo Co. Ltd. – Key offerings
o Exhibit 158: Toyobo Co. Ltd. – Segment focus
o 12.17 WuXi Biologics Cayman Inc.
o Exhibit 159: WuXi Biologics Cayman Inc. – Overview
o Exhibit 160: WuXi Biologics Cayman Inc. – Product / Service
o Exhibit 161: WuXi Biologics Cayman Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Product Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global biologics CDMO market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Product type Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Mammalian – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Mammalian – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Mammalian – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Mammalian – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Microbial – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Microbial – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Microbial – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Microbial – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Chart on Product Type – Market share 2022-2027 (%)
Exhibits44: Data Table on Product Type – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Product Type
Exhibits46: Data Table on Comparison by Product Type
Exhibits47: Chart on Biologics – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on Biologics – Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on Biologics – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Biologics – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Biosimilars – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Biosimilars – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Biosimilars – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Biosimilars – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Product Type ($ billion)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share by geography 2022-2027 (%)
Exhibits58: Data Table on Market share by geography 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on France – Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on France – Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity by geography ($ billion)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: AbbVie Inc. – Overview
Exhibits105: AbbVie Inc. – Product / Service
Exhibits106: AbbVie Inc. – Key news
Exhibits107: AbbVie Inc. – Key offerings
Exhibits108: Binex Co. Ltd. – Overview
Exhibits109: Binex Co. Ltd. – Product / Service
Exhibits110: Binex Co. Ltd. – Key offerings
Exhibits111: Boehringer Ingelheim International GmbH – Overview
Exhibits112: Boehringer Ingelheim International GmbH – Business segments
Exhibits113: Boehringer Ingelheim International GmbH – Key news
Exhibits114: Boehringer Ingelheim International GmbH – Key offerings
Exhibits115: Boehringer Ingelheim International GmbH – Segment focus
Exhibits116: Bora Pharmaceuticals Co. Ltd. – Overview
Exhibits117: Bora Pharmaceuticals Co. Ltd. – Product / Service
Exhibits118: Bora Pharmaceuticals Co. Ltd. – Key offerings
Exhibits119: Catalent Inc. – Overview
Exhibits120: Catalent Inc. – Business segments
Exhibits121: Catalent Inc. – Key news
Exhibits122: Catalent Inc. – Key offerings
Exhibits123: Catalent Inc. – Segment focus
Exhibits124: Evonik Industries AG – Overview
Exhibits125: Evonik Industries AG – Business segments
Exhibits126: Evonik Industries AG – Key news
Exhibits127: Evonik Industries AG – Key offerings
Exhibits128: Evonik Industries AG – Segment focus
Exhibits129: FUJIFILM Holdings Corp – Overview
Exhibits130: FUJIFILM Holdings Corp – Business segments
Exhibits131: FUJIFILM Holdings Corp – Key offerings
Exhibits132: FUJIFILM Holdings Corp – Segment focus
Exhibits133: Grifols SA – Overview
Exhibits134: Grifols SA – Business segments
Exhibits135: Grifols SA – Key offerings
Exhibits136: Grifols SA – Segment focus
Exhibits137: JRS PHARMA GmbH and Co. KG – Overview
Exhibits138: JRS PHARMA GmbH and Co. KG – Product / Service
Exhibits139: JRS PHARMA GmbH and Co. KG – Key offerings
Exhibits140: Lonza Group Ltd. – Overview
Exhibits141: Lonza Group Ltd. – Business segments
Exhibits142: Lonza Group Ltd. – Key news
Exhibits143: Lonza Group Ltd. – Key offerings
Exhibits144: Lonza Group Ltd. – Segment focus
Exhibits145: Novartis AG – Overview
Exhibits146: Novartis AG – Business segments
Exhibits147: Novartis AG – Key offerings
Exhibits148: Novartis AG – Segment focus
Exhibits149: Rentschler Biopharma SE – Overview
Exhibits150: Rentschler Biopharma SE – Product / Service
Exhibits151: Rentschler Biopharma SE – Key offerings
Exhibits152: Samsung Biologics Co. Ltd. – Overview
Exhibits153: Samsung Biologics Co. Ltd. – Product / Service
Exhibits154: Samsung Biologics Co. Ltd. – Key offerings
Exhibits155: Toyobo Co. Ltd. – Overview
Exhibits156: Toyobo Co. Ltd. – Business segments
Exhibits157: Toyobo Co. Ltd. – Key offerings
Exhibits158: Toyobo Co. Ltd. – Segment focus
Exhibits159: WuXi Biologics Cayman Inc. – Overview
Exhibits160: WuXi Biologics Cayman Inc. – Product / Service
Exhibits161: WuXi Biologics Cayman Inc. – Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations
|
| ※본 조사보고서 [세계의 생물 제제 CDMO 시장 (2023~2027) : 포유류, 미생물] (코드 : IRTNTR72001-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 생물 제제 CDMO 시장 (2023~2027) : 포유류, 미생물] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
